CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Ost-müük Eagle Pharm - EGRX CFD

    -
    0%
    • Kokkuvõte
    • Ajaloolised andmed
    • Sündmused
    • Tuluaruanne
    • Bilanss
    • Rahavood
    • Omand
    Kauplemistingimused
    Hinnavahe -
    Pika positsiooni ööpäeva tasu

    Long position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		-0.024874%
    Lühikese positsiooni ööpäeva tasu

    Short position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		0.002651%
    Ööpäeva tasu aeg 21:00 (UTC)
    Min kauplemise kogus 1
    Valuuta USD
    Tagatis 20%
    Aktsiabörs United States of America
    Kauplemise vahendustasu 0%

    *Information provided by Capital.com

    Võtmestatistika
    Eelmine sulgemine* N/A
    Avatud* N/A
    Aastane muutus* N/A
    Päeva ulatus* N/A
    52 nädala ulatus 23.87-51.60
    Keskmine maht (10 päeva) 289.29K
    Keskmine maht (3 kuud) 3.43M
    Turukapitalisatsioon 364.79M
    P/E suhtarv 10.11
    Ringluses olevad aktsiad 13.08M
    Tulu 316.61M
    EPS 2.76
    Dividendid (% kasumist) N/A
    Beeta 0.91
    Järgmine tuluaruande kuupäev May 8, 2023

    Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Sulgemishind Change (%) Avamishind High Low

    Eagle Pharm Events

    Kellaaeg (UTC) (UTC) Riik Sündmus
    No events scheduled
    Vaadake kõiki sündmusi
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Kogutulu 316.61 171.546 187.802 195.892 213.312
    Tulu 316.61 171.546 187.802 195.892 213.312
    Kulud, Kokku 94.936 42.18 45.465 60.897 61.916
    Brutokasum 221.674 129.366 142.337 134.995 151.396
    Kogu tegevuskulu 235.65 168.777 154.848 174.077 176.696
    Müük/Üldine/admin kulud, kokku 106.626 75.322 78.598 76.37 60.509
    Uuringud ja arendus 34.088 51.275 30.785 36.81 44.419
    Ootamatud kulutused (tulu) 0 0 10.615
    Tulud majandustegevusest 80.96 2.769 32.954 21.815 36.616
    Intressitulud (kulu), muud tulud, neto -3.774 -7.275 -2.015 -0.517 -2.578
    Muud, neto -15.753 -0.042 -8.262 0.7
    Netotulu enne makse 61.433 -4.548 22.677 21.998 34.038
    Netotulu pärast makse 35.642 -8.627 11.989 14.313 31.903
    Netotulu enne erikulusid 35.642 -8.627 11.989 14.313 31.903
    Netotulu 35.642 -8.627 11.989 14.313 31.903
    Total Adjustments to Net Income
    Arvestatav tulu, v a erikulud 35.642 -8.627 11.989 14.313 31.903
    Arvestatav tulu, koos erikuludega 35.642 -8.627 11.989 14.313 31.903
    Jaotamisele kuuluv netotulu 35.642 -8.627 11.989 14.313 31.903
    Keskmine jaotamisele kuuluv aktsia kohta 13.0655 13.0511 13.7714 14.1387 15.2787
    Jaotatav EPS, v a erakorralised kulud 2.72795 -0.66102 0.87057 1.01233 2.08808
    Jaotamisele kuuluv normaal-EPS 3.11654 -0.66102 0.87057 1.01233 2.73926
    Other Operating Expenses, Total 0 0 -0.763
    Erakorralised kulud kokku
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Kogutulu 60.699 65.901 74.136 115.874 42.32
    Tulu 60.699 65.901 74.136 115.874 42.32
    Kulud, Kokku 19.866 23.651 23.664 27.755 12.309
    Brutokasum 40.833 42.25 50.472 88.119 30.011
    Kogu tegevuskulu 51.233 56.439 71.933 56.045 36.421
    Müük/Üldine/admin kulud, kokku 24.15 23.462 36.832 22.182 20.325
    Uuringud ja arendus 7.217 9.326 11.437 6.108 3.787
    Tulud majandustegevusest 9.466 9.462 2.203 59.829 5.899
    Intressitulud (kulu), muud tulud, neto -1.663 -1.591 -1.008 -2.712 -4.53
    Muud, neto 5.501 -11.534 -7.063 0.543 -0.145
    Netotulu enne makse 13.304 -3.663 -5.868 57.66 1.224
    Netotulu pärast makse 8.165 -7.131 -9.45 44.058 -6.196
    Netotulu enne erikulusid 8.165 -7.131 -9.45 44.058 -6.196
    Netotulu 8.165 -7.131 -9.45 44.058 -6.196
    Arvestatav tulu, v a erikulud 8.165 -7.131 -9.45 44.058 -6.196
    Arvestatav tulu, koos erikuludega 8.165 -7.131 -9.45 44.058 -6.196
    Jaotamisele kuuluv netotulu 8.165 -7.131 -9.45 44.058 -6.196
    Keskmine jaotamisele kuuluv aktsia kohta 13.1694 13.1669 12.8361 12.9068 12.8948
    Jaotatav EPS, v a erakorralised kulud 0.62 -0.54158 -0.7362 3.41355 -0.4805
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Jaotamisele kuuluv normaal-EPS 0.6234 -0.54158 -0.7362 3.41355 -0.4805
    • Aastas
    • Kvartalis
    2021 2020 2019 2018 2017
    Käibevarad kokku 172.606 166.065 179.449 163.844 188.697
    Raha ja lühiajalised investeeringud 97.659 103.155 109.775 78.791 114.657
    Raha ja ekvivalendid 97.659 103.155 109.775 78.791 114.657
    Laekumata arved, neto 41.149 51.117 48.004 66.486 53.821
    Accounts Receivable - Trade, Net 41.149 51.117 48.004 66.486 53.821
    Total Inventory 21.908 8.075 6.566 8.304 5.118
    Prepaid Expenses 11.89 3.718 15.104 10.263 15.101
    Total Assets 253.732 253.19 254.554 238.603 270.06
    Property/Plant/Equipment, Total - Net 1.636 2.077 5.918 2.397 6.82
    Property/Plant/Equipment, Total - Gross 7.591 7.268 10.237 5.744 9.258
    Accumulated Depreciation, Total -5.955 -5.191 -4.319 -3.347 -2.438
    Goodwill, Net 39.743 39.743 39.743 39.743 39.743
    Intangibles, Net 10.671 12.917 15.583 18.103 23.322
    Other Long Term Assets, Total 29.076 32.388 13.861 14.516 11.478
    Total Current Liabilities 74.376 38.085 38.823 39.686 47.302
    Accounts Payable 16.431 6.268 5.462 9.917 27.036
    Accrued Expenses 32.338 23.817 28.361 23.519 15.391
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total
    Total Liabilities 77.279 67.179 75.38 77.841 90.916
    Total Long Term Debt 0 25.135 33.557 38.155 42.905
    Other Liabilities, Total 2.903 3.959 3 0 0.709
    Total Equity 176.453 186.011 179.174 160.762 179.144
    Common Stock 0.017 0.017 0.017 0.017 0.016
    Additional Paid-In Capital 325.779 305.403 278.518 256.458 233.639
    Retained Earnings (Accumulated Deficit) 75.862 84.489 72.5 58.187 26.284
    Treasury Stock - Common -225.111 -203.898 -171.861 -153.9 -80.795
    Total Liabilities & Shareholders’ Equity 253.732 253.19 254.554 238.603 270.06
    Total Common Shares Outstanding 12.7914 13.057 13.6302 13.914 14.8477
    Current Port. of LT Debt/Capital Leases 25.607 8 5 6.25 4.875
    Long Term Debt 0 25.135 33.557 38.155 42.905
    Redeemable Preferred Stock 0 0 0 0
    Other Equity, Total -0.094
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Käibevarad kokku 240.166 172.606 171.694 175.504 163.986
    Raha ja lühiajalised investeeringud 69.522 97.659 99.741 108.717 105.229
    Raha ja ekvivalendid 69.522 97.659 99.741 108.717 105.229
    Laekumata arved, neto 130.858 41.149 47.081 52.659 44.868
    Accounts Receivable - Trade, Net 130.858 41.149 45.335 52.659 44.868
    Total Inventory 24.818 21.908 9.315 8.294 6.862
    Prepaid Expenses 14.968 11.89 15.557 5.834 7.027
    Total Assets 320.165 253.732 256.261 264.242 259.968
    Property/Plant/Equipment, Total - Net 1.627 1.636 1.775 1.967 2.27
    Property/Plant/Equipment, Total - Gross 7.759 7.591 7.542 7.537 7.652
    Accumulated Depreciation, Total -6.132 -5.955 -5.767 -5.57 -5.382
    Goodwill, Net 39.743 39.743 39.743 39.743 39.743
    Intangibles, Net 9.94 10.671 10.799 11.505 12.211
    Other Long Term Assets, Total 28.689 29.076 32.25 35.523 41.758
    Total Current Liabilities 101.642 74.376 48.431 44.664 41.973
    Accounts Payable 14.509 16.431 12.717 11.136 12.559
    Accrued Expenses 63.408 32.338 27.714 25.528 21.414
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 23.725 25.607 8 8 8
    Total Liabilities 104.205 77.279 70.968 69.395 68.89
    Total Long Term Debt 0 0 19.489 21.371 23.253
    Long Term Debt 0 19.489 21.371 23.253
    Other Liabilities, Total 2.563 2.903 3.048 3.36 3.664
    Total Equity 215.96 176.453 185.293 194.847 191.078
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.017 0.017 0.017 0.017 0.017
    Additional Paid-In Capital 328.769 325.779 320.566 316.249 312.323
    Retained Earnings (Accumulated Deficit) 119.92 75.862 82.058 87.68 84.068
    Treasury Stock - Common -233.164 -225.111 -216.466 -208.195 -205.33
    Total Liabilities & Shareholders’ Equity 320.165 253.732 256.261 264.242 259.968
    Total Common Shares Outstanding 12.6971 12.7914 12.9446 13.0971 13.1455
    Other Equity, Total 0.418 -0.094 -0.882 -0.904
    • Aastas
    • Kvartalis
    2021 2020 2019 2018 2017
    Netotulu/algväärtus -8.627 11.989 14.313 31.903 51.943
    Raha majandustegevusest 28.219 49.497 55.986 52.384 58.919
    Raha majandustegevusest 0.764 0.872 2.131 1.155 0.932
    Amortization 2.996 2.666 2.52 2.515 2.815
    Deferred Taxes -3.618 -1.511 0.152 -2.468 17.289
    Mittelikviidsed varad 27.167 34.665 22.478 27.168 15.509
    Cash Taxes Paid 10.005 6.428 6.673 2.281 10.542
    Makstud intressid 1.197 2.224 2.478 2.084 0.651
    Muutused tööjõus 9.537 0.816 14.392 -7.889 -29.569
    Tulu investeeringutelt -5.323 -18.247 -0.777 -0.133 -5.186
    Kapitalikulutused -0.323 -0.747 -0.777 -0.133 -5.186
    Muud rahavood investeeringutelt, kokku -5 -17.5 0 0
    Rahavood investeeringutelt -28.392 -37.87 -24.225 -88.117 8.104
    Rahavoogudesse investeerimine -1.577 -1.525 -0.524 -19.877 -1.192
    Aktsiate emiteerimine (tagasiost), neto -18.815 -31.345 -17.701 -64.49 -39.454
    Rahaline kogumuutus -5.496 -6.62 30.984 -35.866 61.837
    Laenu väljastamine (kustutamine), neto -8 -5 -6 -3.75 48.75
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line 44.058 -8.627 -2.431 3.191 -0.421
    Cash From Operating Activities -16.611 28.219 20.138 19.071 10.478
    Cash From Operating Activities 0.177 0.764 0.575 0.378 0.19
    Amortization 0.731 2.996 2.118 1.412 0.706
    Deferred Taxes -2.432 -3.618 -2.533 1.119 0.902
    Non-Cash Items 6.616 27.167 17.689 10.989 1.378
    Cash Taxes Paid 0.041 10.005 6.303 4.3 0.267
    Cash Interest Paid 0.265 1.197 0.917 0.625 0.321
    Changes in Working Capital -65.761 9.537 4.72 1.982 7.723
    Cash From Investing Activities -0.168 -5.323 -5.274 -5.269 -5.384
    Capital Expenditures -0.168 -0.323 -0.274 -0.269 -0.384
    Other Investing Cash Flow Items, Total 0 -5 -5 -5 -5
    Cash From Financing Activities -11.358 -28.392 -18.278 -8.24 -3.02
    Financing Cash Flow Items -1.305 -1.577 -1.551 -1.551 -1.551
    Issuance (Retirement) of Stock, Net -8.053 -18.815 -10.727 -2.689 0.531
    Issuance (Retirement) of Debt, Net -2 -8 -6 -4 -2
    Net Change in Cash -28.137 -5.496 -3.414 5.562 2.074
    Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
    BlackRock Institutional Trust Company, N.A. Investment Advisor 12.5019 1635783 7863 2022-12-31 LOW
    Tarriff (Scott L) Individual Investor 12.2764 1606275 70900 2023-03-01 LOW
    Janus Henderson Investors Investment Advisor/Hedge Fund 9.3996 1229872 -9907 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 7.2761 952026 -59721 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.8236 761974 -11708 2022-12-31 LOW
    Brandes Investment Partners, L.P. Investment Advisor 3.1807 416177 -51680 2022-12-31 LOW
    Adage Capital Management, L.P. Hedge Fund 3.0571 400000 150000 2022-12-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.672 349606 -6153 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 2.0379 266650 -7629 2022-12-31 HIGH
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.77 231587 -79633 2022-12-31 MED
    Smith, Graham & Co. Investment Advisors, L.P. Investment Advisor 1.7672 231222 -799 2022-12-31 LOW
    Quoniam Asset Management GmbH Investment Advisor/Hedge Fund 1.7569 229871 -55740 2022-12-31 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5309 200305 3708 2022-12-31 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 1.2452 162931 19807 2022-12-31 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.2246 160236 -2596 2022-12-31 LOW
    LSV Asset Management Investment Advisor 1.1573 151418 126068 2022-12-31 LOW
    Allspring Global Investments, LLC Investment Advisor/Hedge Fund 1.1512 150628 62456 2022-12-31 LOW
    Scout Investments, Inc. Investment Advisor 1.0749 140642 -2342 2022-12-31 MED
    AQR Capital Management, LLC Investment Advisor/Hedge Fund 1.0342 135315 39400 2022-12-31 LOW
    Morgan Stanley & Co. LLC Research Firm 1.0278 134477 -15478 2022-12-31 MED

    Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

    Capital.com Group

    500K+

    Kauplejad

    92K+

    Igakuiste aktiivsete klientide arv

    $53M+

    Igakuine investeerimise maht

    $30M+

    Igakuiselt välja võetud

    Kauplemiskalkulaator

    Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).

    Kauplemise vahendustasu
    0
    • 1:1
    Finantsvõimendus
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investeering
    Tehingu suurus (võimendus x investeering):
    Avamishind

    Close

    Lühike Pikk
    Varasem tootlikkus ei ole tuleviku tulemuste hindamiseks usaldusväärne indikaator
    Kasum/Kaotus

    Eagle Pharm Company profile

    Ettevõttest Eagle Pharm

    Eagle Pharmaceuticals, Inc. on integreeritud farmaatsiaettevõte. Ettevõte viib molekuli prekliinilistest uuringutest läbi regulatiivse heakskiitmise ja turuleviimise, sealhulgas arenduse, tootmise ja turustamise. Ettevõte tuvastab kesknärvisüsteemi või metaboolse kriitilise hoolduse ravivaldkondades, samuti onkoloogias esinevaid raskesti ravitavaid haigusi. Ettevõte pakub kolme toodet: Ryanodex, dantroleennaatrium) (Ryanodex), bendamustiini lahjendusvalmis (RTD) 500 ml lahus (Belrapzo) ja kiiresti infundeeritav bendamustiini RTD (Bendeka). Ettevõte turustab Ryanodexi ja Belrapzo ning Teva Pharmaceutical Industries Ltd. (Teva) turustab Bendeka lüofiliseeritud bendamustiinvesinikkloriidi pulbrilist ravimvormi Jaapanis.

    Industry: Proprietary & Advanced Pharmaceuticals

    50 Tice Boulevard, Suite 315
    07677

    Tuluaruanne

    • Annual
    • Quarterly

    Teised on vaadanud veel

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0185%
    Lühikese positsiooni ööpäeva tasu 0.0102%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.30

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0156%
    Lühikese positsiooni ööpäeva tasu -0.0063%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0249%
    Lühikese positsiooni ööpäeva tasu 0.0027%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 3.0

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.4092%
    Lühikese positsiooni ööpäeva tasu 0.3873%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.005

    Kas otsite jätkuvalt vahendajat, keda saab usaldada?

    Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

    1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist